PEGylation of proteins in organic solution: A case study for interferon beta-1b

Bioconjugate Chemistry

Volumn 23, Issue 9, 2012, Pages 1812-1820

  Peng, Fei ^a,b   Wang, Yinjue ^a   Sun, Lijing ^a   Liu, Yongdong ^a   Hu, Tao ^a   Zhang, Guifeng ^a   Ma, Guanghui ^a   Su, Zhiguo ^a  

^a INSTITUTE OF PROCESS ENGINEERING   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AGGREGATES; ATOMIC FORCE MICROSCOPY; DICHROISM; DYNAMIC LIGHT SCATTERING; HYDROPHOBICITY; PROTEINS;

2-BUTANOL; ANTIVIRALS; CASE-STUDIES; HYDROPHOBIC PROTEIN; INTERFERON BETAS; ORGANIC SOLUTIONS; PEGYLATED; PEGYLATION; PROTEIN PEGYLATION; PROTEIN SEPARATIONS;

SOLUTIONS;

2 BUTANOL; INTERFERON BETA SERINE; PEGINTERFERON; WATER;

ANIMAL EXPERIMENT; ANTIVIRAL ACTIVITY; AQUEOUS SOLUTION; ARTICLE; ATOMIC FORCE MICROSCOPY; CIRCULAR DICHROISM; CONTROLLED STUDY; DRUG ACTIVITY; FLUORESCENCE SPECTROSCOPY; HYDROPHOBICITY; LIGHT SCATTERING; MALE; NONHUMAN; PEPTIDE MAPPING; PROTEIN AGGREGATION; PROTEIN MODIFICATION; RAT;

EID: 84866406802     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc300081f     Document Type: Article

References (48)

1. Parrott, M. C. and DeSimone, J. M. (2012) Drug delivery: Relieving PEGylation Nat. Chem. 4, 13-14
2. Kontermann, R. E. (2011) Strategies for extended serum half-life of protein therapeutics Curr. Opin. Biotechnol. 22, 868-876
3. Bansal, R., Post, E., Proost, J. H., de Jager-Krikken, A., Poelstra, K., and Prakash, J. (2011) PEGylation improves pharmacokinetic profile, liver uptake and efficacy of Interferon gamma in liver fibrosis J. Controlled Release 154, 233-240
4. Plesner, B., Fee, C. J., Westh, P., and Nielsen, A. D. (2011) Effects of PEG size on structure, function and stability of PEGylated BSA Eur. J. Pharm. Biopharm. 79, 399-405
5. Wang, J., Hu, T., Liu, Y., Zhang, G., Ma, G., and Su, Z. (2011) Kinetic and stoichiometric analysis of the modification process for N-terminal PEGylation of staphylokinase Anal. Biochem. 412, 114-116
6. Eltaweel, M. A., Abd Rahman, R. N. Z. R., Salleh, A. B., and Basri, M. (2005) An organic solvent-stable lipase from Bacillus sp.strain 42 Ann. Microbiol. 55, 187-192 (Pubitemid 41426791)
7. Samarkina, O. N., Popova, A. G., Gvozdik, E. Y., Chkalina, A. V., Zvyagin, I. V., Rylova, Y. V., Rudenko, N. V., Lusta, K. A., Kelmanson, I. V., Gorokhovatsky, A. Y., and Vinokurov, L. M. (2009) Universal and rapid method for purification of GFP-like proteins by the ethanol extraction Protein Expression Purif. 65, 108-113
8. Dhake, K. P., Deshmukh, K. M., Wagh, Y. S., Singhal, R. S., and Bhanage, B. M. (2012) Investigation of steapsin lipase for kinetic resolution of secondary alcohols and synthesis of valuable acetates in non-aqueous reaction medium J. Mol. Catal. B: Enzym. 77, 15-23
9. Batistella, L., Lerin, L. A., Brugnerotto, P., Danielli, A. J., Trentin, C. M., Popiolski, A., Treichel, H., Oliveira, J. V., and de Oliveira, D. (2012) Ultrasound-assisted lipase-catalyzed transesterification of soybean oil in organic solvent system Ultrason. Sonochem. 19, 452-458
10. Bridiau, N. and Maugard, T. (2012) Bacillus circulans β-galactosidase catalyses the synthesis of N-acetyl-lactosamine in a hydro-organic medium via a steady-state ordered Bi Bi reaction mechanism J. Mol. Catal. B: Enzym. 77, 24-31
11. Wan, Y. Y., Miyakoshi, T., Du, Y. M., Chen, L. J., Hao, J. M., and Kennedy, J. F. (2012) Mechanism of monolignol biotransformation by Rhus laccases in water-miscible organic solutions Int. J. Biol. Macromol. 50, 530-533
12. Hu, W., Guan, Z., Deng, X., and He, Y. H. (2012) Enzyme catalytic promiscuity: The papain-catalyzed Knoevenagel reaction Biochimie 94, 656-661
13. Gehrhardt, H. and Mutter, M. (1987) Soluble polymers in organic chemistry Polym. Bull. 18, 487-493
14. Fensterl, V. and Sen, G. C. (2009) Interferons and viral infections Biofactors 35, 14-20
15. Theofilopoulos, A. N., Baccala, R., Beutler, B., and Kono, D. H. (2005) Type I interferons (alpha/beta) in immunity and autoimmunity Annu. Rev. Immunol. 23, 307-36 (Pubitemid 40563172)
16. Sun, Y., Qiao, L., Xia, H. H., Lin, M. C., Zou, B., Yuan, Y., Zhu, S., Gu, Q., Cheung, T. K., Kung, H. F., Yuen, M. F., Chan, A. O., and Wong, B. C. (2008) Regulation of XAF1 expression in human colon cancer cell by interferon beta: activation by the transcription regulator STAT1 Cancer Lett. 260, 62-71
17. Sternberg, Z., Chadha, K., Lieberman, A., Hojnacki, D., Drake, A., Zamboni, P., Rocco, P., Grazioli, E., Weinstock-Guttman, B., and Munschauer, F. (2008) Quercetin and interferon-beta modulate immune response(s) in peripheral blood mononuclear cells isolated from multiple sclerosis patients J. Neuroimmunol. 205, 142-7
18. Smith, M. C., Bayless, A. M., Goddard, E. T., and Davido, D. J. (2011) CK2 inhibitors increase the sensitivity of HSV-1 to interferon-beta Antiviral Res. 91, 259-66
19. Mark, D. F., Lu, S. D., Creasey, A. A., Yamamoto, R., and Lin, L. S. (1984) Site-specific mutagenesis of the human fibroblast interferon gene Proc. Natl. Acad. Sci. U. S. A. 81, 5662-6 (Pubitemid 14023825)
20. Conway, D. and Cohen, J. A. (2010) Combination therapy in multiple sclerosis Lancet Neurol. 9, 299-308
21. Kappos, L., Freedman, M. S., Polman, C. H., Edan, G., Hartung, H. P., Miller, D. H., Montalban, X., Barkhof, F., Radu, E. W., Metzig, C., Bauer, L., Lanius, V., Sandbrink, R., and Pohl, C. (2009) Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial Lancet Neurol. 8, 987-97
22. Fernandes, P. M. and Taforo, T. (1991) Formulations for lipophilic IL-2 proteins. U.S. Patent 4,992,271.
23. Hershenson, S. and Thomson, J. (1989) Isoelectric focusing of recombinant interferon-beta Appl. Theor. Electrophor. 1, 123-5
24. Nikfar, S., Rahimi, R., and Abdollahi, M. (2010) A meta-analysis of the efficacy and tolerability of interferon-beta in multiple sclerosis, overall and by drug and disease type Clin. Ther. 32, 1871-88
25. Burks, J. (2005) Interferon-beta1b for multiple sclerosis Expert Rev. Neurother. 5, 153-64
26. Yu, P., Qin, D., Qin, G., Fan, B., Ma, G., and Su, Z. (2009) PEGylation of rhIL-1RA increased its solution stability at room temperature Process Biochem. 44, 1340-1345
27. Pasut, G. and Veronese, F. M. (2011) State of the art in PEGylation: The great versatility achieved after forty years of research J. Controlled Release 10.1016/j.jconrel.2011.10.037
28. Bansal, R., Post, E., Proost, J. H., de Jager-Krikken, A., Poelstra, K., and Prakash, J. (2011) PEGylation improves pharmacokinetic profile, liver uptake and efficacy of Interferon gamma in liver fibrosis J. Controlled Release 154, 233-40
29. Katre, N. and Knauf, M. J. (1990) Solubilization of immunotoxins for pharmaceutical compositions using polymer conjugation. U.S. Patent 4,917,888.
30. Basu, A., Yang, K., Wang, M., Liu, S., Chintala, R., Palm, T., Zhao, H., Peng, P., Wu, D., Zhang, Z., Hua, J., Hsieh, M. C., Zhou, J., Petti, G., Li, X., Janjua, A., Mendez, M., Liu, J., Longley, C., Mehlig, M., Borowski, V., Viswanathan, M., and Filpula, D. (2006) Structure-function engineering of interferon-beta-1b for improving stability, solubility, potency, immunogenicity, and pharmacokinetic properties by site-selective mono-PEGylation Bioconjugate Chem. 17, 618-30 (Pubitemid 43794371)
31. Zhao, H., Yang, K., Martinez, A., Basu, A., Chintala, R., Liu, H. C., Janjua, A., Wang, M., and Filpula, D. (2006) Linear and branched bicin linkers for releasable PEGylation of macromolecules: controlled release in vivo and in vitro from mono- and multi-PEGylated proteins Bioconjugate Chem. 17, 341-51
32. Thom, J., Anderson, D., McGregor, J., and Cotton, G. (2011) Recombinant protein hydrazides: application to site-specific protein PEGylation Bioconjugate Chem. 22, 1017-20
33. Boublik, M., Moschera, J. A., Wei, C., and Kung, H. F. (1990) Conformation and activity of recombinant human fibroblast interferon-beta J. Interferon Res. 10, 213-9 (Pubitemid 20138714)
34. Utsumi, J., Yamazaki, S., Hosoi, K., Kimura, S., Hanada, K., Shimazu, T., and Shimizu, H. (1987) Characterization of E. coli-derived recombinant human interferon-beta as compared with fibroblast human interferon-beta J. Biochem. 101, 1199-208 (Pubitemid 17060306)
35. Lin, L. S., Yamamoto, R., and Drummond, R. J. (1986) Purification of recombinant human interferon beta expressed in Escherichia coli Methods Enzymol. 119, 183-92 (Pubitemid 16025111)
36. Mosmann, T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J. Immunol. Methods 65, 55-63 (Pubitemid 14203433)
37. Tiso, M., Tejero, J., Basu, S., Azarov, I., Wang, X., Simplaceanu, V., Frizzell, S., Jayaraman, T., Geary, L., Shapiro, C., Ho, C., Shiva, S., Kim-Shapiro, D. B., and Gladwin, M. T. (2011) Human neuroglobin functions as a redox-regulated nitrite reductase J. Biol. Chem. 286, 18277-89
38. De Caro, C. A., Aichert, A., and Walter, C. M. (2001) Efficient, precise and fast water determination by the Karl Fischer titration Food Control 12, 431-436 (Pubitemid 33627765)
39. Olkowska, E., Polkowska, Ż., and Namieśnik, J. Analytical procedures for the determination of surfactants in environmental samples. Talanta Doi: 10.1016/j.talanta.2011.10.034.
40. Utsumi, J., Yamazaki, S., Kawaguchi, K., Kimura, S., and Shimizu, H. (1989) Stability of human interferon-beta 1: oligomeric human interferon-beta 1 is inactive but is reactivated by monomerization Biochim. Biophys. Acta 998, 167-72 (Pubitemid 19241541)
41. Ghaouar, N., Elmissaoui, S., Aschi, A., and Gharbi, A. (2010) Concentration regimes and denaturation effects on the conformational changes of alpha-chymotrypsin by viscosity and dynamic light scattering measurements Int. J. Biol. Macromol. 47, 425-430
42. Cardoso, T., Oliveira, C., Sarmento, A. C., Pereira, A., Nutley, M. A., Jess, T., Kelly, S. M., Cooper, A., Price, N. C., Pires, E., and Barros, M. (2009) Acetonitrile-induced unfolding of porcine pepsin A: A proposal for a critical role of hydration structures in conformational stability Int. J. Biol. Macromol. 45, 213-220
43. Oliver-Martos, B., Orpez, T., Pinto-Medel, M. J., Mayorga, C., Garcia-Leon, J. A., Maldonado-Sanchez, R., Suardiaz, M., Guerrero, M., Luque, G., Leyva, L., and Fernandez, O. (2011) Gene expression in IFNss signalling pathway differs between monocytes, CD4 and CD8 T cells from MS patients J. Neuroimmunol. 230, 153-9
44. de Weerd, N. A., Samarajiwa, S. A., and Hertzog, P. J. (2007) Type I interferon receptors: biochemistry and biological functions J. Biol. Chem. 282, 20053-7 (Pubitemid 47099976)
45. Novick, D., Cohen, B., and Rubinstein, M. (1994) The human interferon alpha/beta receptor: characterization and molecular cloning Cell 77, 391-400 (Pubitemid 24145200)
46. Domanski, P., Witte, M., Kellum, M., Rubinstein, M., Hackett, R., Pitha, P., and Colamonici, O. R. (1995) Cloning and expression of a long form of the beta subunit of the interferon alpha beta receptor that is required for signaling J. Biol. Chem. 270, 21606-11
47. Lutfalla, G., Holland, S. J., Cinato, E., Monneron, D., Reboul, J., Rogers, N. C., Smith, J. M., Stark, G. R., Gardiner, K., and Mogensen, K. E. 1995, Mutant U5A cells are complemented by an interferon-alpha beta receptor subunit generated by alternative processing of a new member of a cytokine receptor gene cluster EMBO J. 14, 5100-8
48. Runkel, L., deDios, C., Karpusas, M., Betzenhauser, M., Muldowney, C., Zafari, M., Benjamin, C. D., Miller, S., Hochman, P. S., and Whitty, A. (2000) Systematic mutational mapping of sites on human interferon-beta-1a that are important for receptor binding and functional activity Biochemistry 39, 2538-51 (Pubitemid 30148906)